Pharma Focus Asia

Umoja Biopharma Plans to Construct New Manufacturing Facility in Colourado, USA


Umoja Biopharma plans for the construction of a new state-of-the-art laboratory and innovative manufacturing facility in Colourado, USA.


The facility is designed to accelerate therapeutic candidate development. 

The first phase covers 77,000 square feet, housing cutting-edge labs, offices, and manufacturing areas tailored for lentiviral vector production. 

This space is designed with the flexibility to expand to 146,000 square feet, aligning seamlessly with anticipated future supply requirements.

The opening of this facility will support the development and commercialisation of gene therapies that can scale effectively by creating a significant and meaningful impact on the lives of patients globally.

This facility is set to drive in-house tech development, guarantee top-notch quality for clinical trials, and establish a robust, adaptable supply chain foundation.

The laboratory & innovative manufacturing building is is projected for the first quarter of 2024.


Name  Umoja Biopharma
Type    New Construction
Year     2024

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference